Physician profile
John H Marks
NPI 1346212594
$154,564.23
in general payments reported to CMS, 2019-2025
55 companies · $45K in 2025
The $45K reported for 2025 was more than what 98% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $7,931 · 2021: $21K · 2022: $8,805 · 2023: $22K · 2024: $28K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $76K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,590 · Food and Beverage: $4,680 · Education: $4,000 · Travel and Lodging: $2,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,665.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,590.00 |
| Food and Beverage | $4,680.39 |
| Education | $4,000.00 |
| Travel and Lodging | $2,968.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $44,316.91 | 2019-2025 | Da Vinci Surgical System |
| Vascular Technology, INC. | $35,000.00 | 2023-2025 | |
| Stryker Corporation | $29,759.61 | 2019-2025 | 1788, 1688, Spy-Phi System |
| Arthrex, INC. | $23,516.88 | 2022-2025 | Arthrex |
| Medtronic, INC. | $14,241.38 | 2021-2025 | Signia, Eea, Ligasure |
| Covidien Lp | $2,651.19 | 2019 | |
| Applied Medical Resources Corporation | $1,375.00 | 2020-2023 | |
| Virtual Incision Corporation | $526.00 | 2024 | Mira |
| Baxter Healthcare | $264.16 | 2022-2024 | Tisseel |
| Ethicon US, LLC | $264.10 | 2019-2025 | Vicryl, Monocryl, Echelon Flex |
| W. L. Gore & Associates, INC. | $256.21 | 2019-2020 | |
| Ethicon INC. | $244.92 | 2024 | |
| Braintree Laboratories, INC. | $183.72 | 2019-2023 | Suflave |
| Tela Bio, INC. | $172.96 | 2024 | Ovitex 2s |
| Davol INC. | $163.69 | 2019-2023 | Arista Ah Flexitip |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.